Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress - Thailand PR News

 - [Banking](https://thailandbusinessnews.net/category/banking/)
- [Companies](https://thailandbusinessnews.net/category/companies/)
- [Economy](https://thailandbusinessnews.net/category/economy/)
- [Press Releases](https://thailandbusinessnews.net/category/press-release/)
    - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/)
- [Tech](https://thailandbusinessnews.net/category/tech/)
- [Tourism](https://thailandbusinessnews.net/category/tourism/)

    - [Press Release](https://thailandbusinessnews.net/category/press-release/)

# Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress

   #####  Up next

  ![Reallusion's AI Render Brings 3D Precision to AI Image and Video Generation in ComfyUI](https://i0.wp.com/r2.thailandbusinessnews.net/2025/07/AI_Render_beta.jpg?resize=200%2C110&ssl=1 "Reallusion's AI Render Brings 3D Precision to AI Image and Video Generation in ComfyUI")

 [](https://thailandbusinessnews.net/press-release/reallusions-ai-render-brings-3d-precision-to-ai-image-and-video-generation-in-comfyui/)

 ###### [Reallusion's AI Render Brings 3D Precision to AI Image and Video Generation in ComfyUI](https://thailandbusinessnews.net/press-release/reallusions-ai-render-brings-3d-precision-to-ai-image-and-video-generation-in-comfyui/)

  Published on 29 July 2025 #####  Author

#####   [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/)

  ##### Tags

- [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/)

 ![](https://mma.prnasia.com/media2/2739717/Kyowa_Kirin_Logo.jpg?p=medium600 "logo")

PRINCETON, N.J. and TOKYO, July 29, 2025 /PRNewswire/ — Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that results of the Phase 3 ROCKET IGNITE trial of rocatinlimab, an investigational therapy targeting the OX40 receptor (OX40R) in patients with moderate-to-severe atopic dermatitis (AD), will be presented at the European Academy of Dermatology and Venereology (EADV) 2025 Annual Meeting to be held in Paris, France from September 17-20, 2025.

AD, a chronic, heterogeneous, inflammatory disease characterized by skin redness, pruritus, and pain, is driven by skin barrier disruption and T-cell-dependent inflammatory pathways. Expansion of OX40R+ pathogenic T cells leads to T-cell imbalance, a root cause of inflammatory diseases including AD.

Title: Efficacy &amp; Safety of OX-40 Receptor Targeting with Rocatinlimab in Moderate-to-Severe Atopic Dermatitis: Results from the Phase 3 ROCKET-IGNITE Trial

Presenter: Emma Guttman-Yassky, MD, PhD

Date: Friday, September 19thTime: 4:40 – 4:50 pm CESTSession: FC 08 Atopic DermatitisLocation: Paris Convention Centre, Pavillon 7.3, Room W05-W06

About the ROCKET Phase 3 ProgramROCKET is a comprehensive, global Phase 3 clinical trial program comprised of eight studies intended to establish the safety and efficacy profile of rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) as well as multiple dosing regimens.

About Moderate to Severe Atopic DermatitisAtopic dermatitis, the most common form of eczema, is a chronic inflammatory disease that causes excessively dry, itchy skin that can be painful. People with moderate to severe atopic dermatitis experience chronic symptoms, intensified by unpredictable flare-ups that can be painful and disruptive to everyday life. More than half of these patients report severe itching, leading to repeated scratching which can cause the skin to thicken and become vulnerable to infection. Atopic dermatitis (all severities) affects 15-20% of children and up to 10% of adults. T-cell imbalance is a root cause of atopic dermatitis, contributing to clinical manifestations including the disease’s recurring, unpredictable symptoms.

About RocatinlimabRocatinlimab is an anti-OX40 human monoclonal antibody being investigated for the treatment of moderate to severe atopic dermatitis. Rocatinlimab has the potential to be the first and only T-cell rebalancing therapy that inhibits and reduces pathogenic T cells by targeting the OX40 receptor. OX40 is a co-stimulatory receptor responsible for driving systemic and local inflammatory responses in atopic dermatitis and other conditions. It has been reported that effector T cells expressing OX40 are present in the lesions of patients with atopic dermatitis and are critical in the disease pathophysiology.

Rocatinlimab is also being studied for prurigo nodularis, moderate to severe uncontrolled asthma and potentially other conditions where T-cell imbalance is a root cause of inflammation. The initial antibody was discovered in collaboration between Kyowa Kirin and La Jolla Institute for Immunology.

Rocatinlimab is currently under clinical investigation, and its safety and efficacy have not been evaluated by the U.S. FDA or any other regulatory authority.

About Kyowa KirinKyowa Kirin aims to discover and deliver novel medicines and treatments with life-changing value. As a Japan-based Global Specialty Pharmaceutical Company, we have invested in drug discovery and biotechnology innovation for more than 70 years and are currently working to engineer the next generation of antibodies and cell and gene therapies with the potential to help patients with high unmet medical needs, such as bone &amp; mineral, intractable hematological diseases/hemato oncology, and rare diseases. A shared commitment to our values, to sustainable growth, and to making people smile unites us across the globe. You can learn more about the business of Kyowa Kirin at: [https://www.kyowakirin.com/](https://c212.net/c/link/?t=0&l=en&o=4476904-1&h=911853552&u=https%3A%2F%2Fwww.kyowakirin.com%2F&a=https%3A%2F%2Fwww.kyowakirin.com%2F).

Amgen and Kyowa Kirin CollaborationOn June 1, 2021, Kyowa Kirin and Amgen entered into an agreement to jointly develop and commercialize rocatinlimab. Under the terms of the agreement, Amgen will lead the development, manufacturing, and commercialization for KHK4083/AMG 451 for all markets globally, except Japan, where Kyowa Kirin will retain all rights. If approved, the companies will co-promote the asset in the United States and Kyowa Kirin has opt-in rights to co-promote in certain other markets including Europe and Asia.

CONTACT:

Kyowa KirinHiroki Nakamura: JapanCorporate Communications Department<media@kyowakirin.com>

Subrenie Thomas-Smith: North AmericaSr. Director, R&amp;D Patient Engagement &amp; Communications<subrenie.thomas-smith.8c@kyowakirin.com>

[Source link ](https://www.prnasia.com/story/archive/4739299_AE39299_0?rand=89749)

```
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
```

  #####  You May Also Like

  [](https://thailandbusinessnews.net/press-release/miniso-debuts-worlds-first-miniso-space-at-deji-plaza-in-nanjing-blending-immersive-ip-experiences-with-luxury-retail/) ![MINISO Debuts World's First MINISO SPACE at Deji Plaza in Nanjing, Blending Immersive IP Experiences with Luxury Retail](https://i0.wp.com/r2.thailandbusinessnews.net/2025/06/1750845863_1.jpg?resize=260%2C140&ssl=1 "MINISO Debuts World's First MINISO SPACE at Deji Plaza in Nanjing, Blending Immersive IP Experiences with Luxury Retail")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)

 ## MINISO Debuts World's First MINISO SPACE at Deji Plaza in Nanjing, Blending Immersive IP Experiences with Luxury Retail

  NANJING, China, June 25, 2025 /PRNewswire/ — Global lifestyle brand MINISO celebrated…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- June 25, 2025

   [](https://thailandbusinessnews.net/press-release/colebrook-bosson-saunders-chooses-india-for-first-executive-dialogue-exploring-future-of-workspaces-and-technology/) ![Colebrook Bosson Saunders Chooses India for First Executive Dialogue Exploring Future of Workspaces and Technology](https://i0.wp.com/mma.prnasia.com/media2/2846368/Colebrook_Bosson_Saunders_ExecutiveDialogue_event.jpg?resize=260%2C140&ssl=1 "Colebrook Bosson Saunders Chooses India for First Executive Dialogue Exploring Future of Workspaces and Technology")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)
- [Tech](https://thailandbusinessnews.net/category/tech/)

 ## Colebrook Bosson Saunders Chooses India for First Executive Dialogue Exploring Future of Workspaces and Technology

  MUMBAI, India, Dec. 16, 2025 /PRNewswire/ — Colebrook Bosson Saunders (CBS), a…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- December 16, 2025

   [](https://thailandbusinessnews.net/press-release/lotusflare-selected-to-power-innovative-cross-border-telco-rewards-program/) ## LotusFlare Selected to Power Innovative Cross-Border Telco Rewards Program

  SANTA CLARA, Calif., Feb. 11, 2025 /PRNewswire/ — LotusFlare, a provider of…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- February 11, 2025

 ##### Most Read

- [![Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/finloop-raises-over-us10-million-in-series-a-financing-welcomes-hsbc-as-one-of-its-strategic-investors-and-launches-its-corporate-service-finterprise/ "Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"") [Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"](https://thailandbusinessnews.net/press-release/finloop-raises-over-us10-million-in-series-a-financing-welcomes-hsbc-as-one-of-its-strategic-investors-and-launches-its-corporate-service-finterprise/ "Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"")
- [![Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/chubb-wealth-debuts-evergreen-private-markets-fund-series-with-s64/ "Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64") [Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64](https://thailandbusinessnews.net/press-release/chubb-wealth-debuts-evergreen-private-markets-fund-series-with-s64/ "Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64")
- [![Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/triton-uranium-advances-atlas-project-reports-exploration-target-of-46-56-million-pounds-of-uranium/ "Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium") [Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium](https://thailandbusinessnews.net/press-release/triton-uranium-advances-atlas-project-reports-exploration-target-of-46-56-million-pounds-of-uranium/ "Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium")
- [![Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/adecco-group-announces-salesforces-agentforce-coworker-rollout-across-40-countries/ "Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries") [Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries](https://thailandbusinessnews.net/press-release/adecco-group-announces-salesforces-agentforce-coworker-rollout-across-40-countries/ "Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries")
- [![GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gccl-and-medicover-integrated-clinical-services-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services/ "GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services") [GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services](https://thailandbusinessnews.net/press-release/gccl-and-medicover-integrated-clinical-services-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services/ "GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services")
- [![600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/600-clubs-strong-inspire-brands-asia-continues-regional-expansion-affirms-vision-for-1000-by-2028/ "600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028") [600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028](https://thailandbusinessnews.net/press-release/600-clubs-strong-inspire-brands-asia-continues-regional-expansion-affirms-vision-for-1000-by-2028/ "600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028")

##### Subscribe via Email

 Enter your email address to subscribe and receive notifications of new posts by email.

  Email Address

       Subscribe

  [](https://thailandbusinessnews.net/press-release/huawei-ekit-launches-intelligent-office-solution-2-0-making-intelligent-office-accessible-to-all/) ![HUAWEI eKit Launches Intelligent Office Solution 2.0, Making Intelligent Office Accessible to All](https://i0.wp.com/mmx.prnasia.com/media/MS1990595/20260917025829EDT_image_1.jpg?resize=260%2C140&ssl=1 "HUAWEI eKit Launches Intelligent Office Solution 2.0, Making Intelligent Office Accessible to All")

 ## HUAWEI eKit Launches Intelligent Office Solution 2.0, Making Intelligent Office Accessible to All

  SHANGHAI, Sept. 17, 2026 /PRNewswire/ — Sept 16, 2026, at the 2026…

   [](https://thailandbusinessnews.net/press-release/111-inc-receives-unsolicited-preliminary-non-binding-proposal-to-acquire-the-company/) ## 111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company

  SHANGHAI, Sept. 17, 2026 /PRNewswire/ — 111 Inc. ( "111" or the…

   [](https://thailandbusinessnews.net/press-release/csts-enterprises-appoints-carlos-pulido-as-the-regional-leader-to-accelerate-global-sports-hospitality-growth/) ![CSTS Enterprises Appoints Carlos Pulido as the Regional Leader to Accelerate Global Sports Hospitality Growth](https://i0.wp.com/mmx.prnasia.com/media/MS1990586/20260917024624EDT_image_1.jpg?resize=260%2C140&ssl=1 "CSTS Enterprises Appoints Carlos Pulido as the Regional Leader to Accelerate Global Sports Hospitality Growth")

 ## CSTS Enterprises Appoints Carlos Pulido as the Regional Leader to Accelerate Global Sports Hospitality Growth

  NEW YORK and HONG KONG, Sept. 17, 2026 /PRNewswire/ — CSTS Enterprises…

   [](https://thailandbusinessnews.net/press-release/wuxi-xdc-out-licenses-wuxitecan-2-payload-linker-technology-platform-to-ona-therapeutics-to-advance-novel-adc-research-and-development/) ## WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Technology Platform to Ona Therapeutics to Advance Novel ADC Research and Development

  SHANGHAI, Sept. 17, 2026 /PRNewswire/ — WuXi XDC Cayman Inc. ("WuXi…
<!-- Performance optimized by Docket Cache: https://wordpress.org/plugins/docket-cache -->
